文献速递甲状腺疾病

超声监测在儿童甲状腺癌中的应用价值

Utility of Ultrasound Surveillance for Thyroid Cancer in Children.
PubMed 文献 · Thyroid · 2025-01-31

本研究为回顾性队列研究,纳入1998至2022年诊断的112例儿童分化型甲状腺癌患者,评估初始治疗后1年超声监测对颈部残留或复发结构性疾病的检测价值。结果显示,初始治疗反应极佳的患者无颈部结构性病变发生,而反应不确定的患者中17.6%出现该病变,超声或甲状腺球蛋白/抗体异常可检测到多数病例。

要点

  • 初始治疗反应极佳患儿随访中无颈部结构性病变发生,连续超声监测价值有限。
  • 反应不确定患儿中17.6%出现颈部结构性病变,超声检出77.8%。
  • 反应极佳患儿中29.5%出现超声假阳性不确定或异常发现。

核心结论

  • 初始治疗反应极佳的儿童分化型甲状腺癌患者,连续超声监测价值受限于颈部结构性病变低风险和高假阳性率。
  • 初始治疗反应不确定的儿童中颈部结构性病变发生比例显著,可通过超声或甲状腺球蛋白/抗体异常检测。

研究设计与样本

  • 回顾性队列研究,纳入1998至2022年诊断的儿童(<19岁)分化型甲状腺癌患者,初始治疗(甲状腺切除术±放射性碘)后1年治疗反应为极佳或不确定者共112例。

主要发现

  • 112例患者中1年治疗反应极佳61例(54.5%),不确定51例(45.5%)。
  • 后续随访中位时长6.4年(四分位距3.8-8.9年),共行683次颈部超声监测,平均每人每年1.0±0.4次。
  • 61例反应极佳患者随访期间无一例发生颈部结构性病变;18例(29.5%)出现超声假阳性不确定或异常发现。
  • 51例反应不确定患者中9例(17.6%)发生颈部结构性病变,超声检出7/9例(77.8%),I-123扫描检出而超声未检出2例(22.2%),此2例均有甲状腺球蛋白/抗体异常;7/9例(77.8%)颈部结构性病变可通过甲状腺球蛋白/抗体检测发现。
  • 共17/112例(15.2%)行细针穿刺,其中6例诊断颈部结构性病变;11/112例(9.8%)行细针穿刺但未诊断颈部结构性病变。

临床怎么用

  • 作者认为,初始治疗反应极佳的儿童分化型甲状腺癌患者中,连续超声监测的价值受限于颈部结构性病变低风险和高假阳性率。
  • 作者认为,初始治疗反应不确定的儿童中颈部结构性病变发生比例显著,可通过超声或甲状腺球蛋白/抗体异常检测,这些患者可能受益于超声与生化监测联合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Differentiated thyroid cancer (DTC) is the most common pediatric endocrine malignancy. The utility of ultrasound (US) surveillance after initial treatment has not been clearly delineated. We sought to evaluate the clinical utility of US for the detection of residual or recurrent disease in pediatric patients with thyroid cancer beginning 1 year after initial therapy. Methods: This is a retrospective cohort study of pediatric patients (<19 years) diagnosed with DTC between 1998 and 2022 whose response to therapy (RTT) one year after initial treatment (thyroidectomy ± radioactive iodine) was excellent or indeterminate. We evaluated the association between sonographic and biochemical findings (thyroglobulin [Tg] and Tg antibodies [TgAb]) at one year with the subsequent diagnosis of residual/recurrent structural disease in the neck (SDN). Results: In total, 112 patients had 1-year RTT that was excellent (n = 61, 54.5%) or indeterminate (n = 51, 45.5%). Median length of subsequent follow-up was 6.4 (interquartile range 3.8-8.9) years. Overall, 683 surveillance neck US were performed, with a mean ± standard deviation of 1.0 ± 0.4 US per patient per year. Of 61 patients with excellent RTT, none developed SDN during follow-up. Eighteen patients (29.5%) had a false-positive indeterminate or abnormal US finding. Of 51 patients with indeterminate RTT, 9 (17.6%) developed SDN during follow-up. SDN was detected by US in 7/9 cases (77.8%). SDN was detected by I-123 scan, but not by US, in two cases (22.2%), both with abnormal Tg/TgAb. 7/9 (77.8%) cases of SDN were detectable by Tg/TgAb. Overall, fine-needle aspiration (FNA) was performed in 17/112 (15.2%) patients and diagnosed SDN in six patients. Overall, 11/112 patients (9.8%) underwent FNA but were not diagnosed with SDN. Conclusions: In pediatric DTC patients with excellent response to initial therapy, the utility of serial US surveillance is limited by the low risk of SDN and frequent false-positive US findings. In children with indeterminate RTT, SDN occurs in a significant proportion and may be detected by US or by abnormal Tg/TgAb levels. These patients may benefit from the combination of US and biochemical surveillance.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Rao S, Frates MC, Benson CB, et al. Utility of Ultrasound Surveillance for Thyroid Cancer in Children. Thyroid. 2025. PMID: 39888311. doi:10.1089/thy.2024.0624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。